David Hutto, Ph.D, DVM, DACVP

Chief Scientific Officer

Dr. Hutto has extensive experience as a nonclinical pharmaceutical scientist and executive and has led key aspects of drug discovery and drug development leading in several cases to drug marketing approvals.  Most recently David was at Charles River Laboratories as the Chief Scientific Officer of Safety Assessment, Veterinary Services and Animal Welfare and prior to that he was the Global Head of Drug Safety at Eisai, a biopharmaceutical company headquartered in Japan.  David is a veterinarian with a PhD in immunology and specialty board certification in pathology and toxicology.